FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream

Barr Pharmaceuticals, Inc. today announced that the U.S. FDA has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application for Synthetic Conjugated Estrogens-A (SCE-A) 0.625 mg/g Vaginal Cream. SCE-A Vaginal Cream is a plant-derived local estrogen product indicated for the treatment of moderate to severe vaginal dryness and pain with intercourse, both of which are symptoms of vulvar and vaginal atrophy due to menopause. It is administered intravaginally at a dose of 1 gram daily for one week, followed by 1 gram intravaginally twice a week.

The details can be read here.